Frontotemporal dementia

Seminars in Neurology

Volumn 33, Issue 4, 2013, Pages 336-341

  Perry, David C ^a   Miller, Bruce L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

frontotemporal dementia; motor neuron disease; neurodegenerative disease; Pick's disease

Indexed keywords

ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; FUSED IN SARCOMA PROTEIN; NEUROLEPTIC AGENT; OLANZAPINE; PROGRANULIN; QUETIAPINE; RISPERIDONE; TAR DNA BINDING PROTEIN; TAU PROTEIN; TRAZODONE; UBIQUITIN; VALOSIN CONTAINING PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; APATHY; ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; BEHAVIOR CHANGE; BRAIN ATROPHY; BULBAR PARALYSIS; CAREGIVER BURDEN; COGNITIVE DEFECT; COMPULSION; COMPUTER ASSISTED TOMOGRAPHY; CORTICOBASAL DEGENERATION; DISEASE COURSE; DNA BINDING; DRUG EFFICACY; EPIDEMIOLOGY; EXTRAPYRAMIDAL SYMPTOM; FAMILY HISTORY; FASCICULATION; FRONTAL VARIANT FRONTOTEMPORAL DEMENTIA; GENE MUTATION; HISTOPATHOLOGY; HUMAN; INCLUSION BODY MYOSITIS; MOLECULAR PATHOLOGY; MOTOR DYSFUNCTION; MOTOR NEURON DISEASE; MUSCLE RIGIDITY; NERVE DEGENERATION; NEUROIMAGING; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OVERNUTRITION; PARKINSONISM; PICK PRESENILE DEMENTIA; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PROSOPAGNOSIA; PSYCHOSIS; SACCADIC EYE MOVEMENT; TAUOPATHY; WEAKNESS;

FRONTOTEMPORAL DEMENTIA; HUMANS;

EID: 84887844492     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0033-1359316     Document Type: Article

References (60)

1. Pick A. Uber die beziehungen der senilen hirnatrophie zur aphasie. Prager Medizinische Wochenschrift: 1892; 17 165 167
2. Alzheimer A. Uber eigenartige krankheitsfalle des sparteren alters. Psychiatr Nervenkr Z Gesamte Neurol Psychiatr: 1911; 4 356 385
3. Johnson J. K., Diehl J., Mendez M. F., et al. Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol: 2005; 62 6 925 930 (Pubitemid 40973454)
4. Knopman D. S., Petersen R. C., Edland S. D., Cha R. H., Rocca W. A. The incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994. Neurology: 2004; 62 3 506 508 (Pubitemid 38200874)
5. Ratnavalli E., Brayne C., Dawson K., Hodges J. R. The prevalence of frontotemporal dementia. Neurology: 2002; 58 11 1615 1621 (Pubitemid 34602891)
6. Rosso S. M., Donker Kaat L., Baks T., et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain: 2003; 126 Pt 9 2016 2022 (Pubitemid 37059441)
7. Mercy L., Hodges J. R., Dawson K., Barker R. A., Brayne C. Incidence of early-onset dementias in Cambridgeshire, United Kingdom. Neurology: 2008; 71 19 1496 1499
8. Roberson E. D., Hesse J. H., Rose K. D., et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology: 2005; 65 5 719 725 (Pubitemid 41285851)
9. Gregory C. A., Serra-Mestres J., Hodges J. R. Early diagnosis of the frontal variant of frontotemporal dementia: how sensitive are standard neuroimaging and neuropsychologic tests? Neuropsychiatry Neuropsychol Behav Neurol: 1999; 12 2 128 135 (Pubitemid 30130778)
10. Hornberger M., Piguet O., Graham A. J., Nestor P. J., Hodges J. R. How preserved is episodic memory in behavioral variant frontotemporal dementia? Neurology: 2010; 74 6 472 479
11. Pasquier F., Grymonprez L., Lebert F., Van der Linden M. Memory impairment differs in frontotemporal dementia and Alzheimer's disease. Neurocase: 2001; 7 2 161 171 (Pubitemid 32457860)
12. Kipps C. M., Nestor P. J., Fryer T. D., Hodges J. R. Behavioural variant frontotemporal dementia: not all it seems? Neurocase: 2007; 13 4 237 247 (Pubitemid 350153953)
13. Khan B. K., Yokoyama J. S., Takada L. T., et al. Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J Neurol Neurosurg Psychiatry: 2012; 83 4 358 364
14. Lomen-Hoerth C., Anderson T., Miller B. The overlap of amyotrophic lateral sclerosis and frontotemporal dementia. Neurology: 2002; 59 7 1077 1079
15. Murphy J. M., Henry R. G., Langmore S., Kramer J. H., Miller B. L., Lomen-Hoerth C. Continuum of frontal lobe impairment in amyotrophic lateral sclerosis. Arch Neurol: 2007; 64 4 530 534 (Pubitemid 46588341)
16. Lomen-Hoerth C., Murphy J., Langmore S., Kramer J. H., Olney R. K., Miller B. Are amyotrophic lateral sclerosis patients cognitively normal? Neurology: 2003; 60 7 1094 1097 (Pubitemid 36418766)
17. Thompson S. A., Patterson K., Hodges J. R. Left/right asymmetry of atrophy in semantic dementia: behavioral-cognitive implications. Neurology: 2003; 61 9 1196 1203 (Pubitemid 37377537)
18. Seeley W. W., Bauer A. M., Miller B. L., et al. The natural history of temporal variant frontotemporal dementia. Neurology: 2005; 64 8 1384 1390 (Pubitemid 40570506)
19. Snowden J. S., Thompson J. C., Neary D. Knowledge of famous faces and names in semantic dementia. Brain: 2004; 127 Pt 4 860 872 (Pubitemid 38478531)
20. Seeley W. W., Crawford R., Rascovsky K., et al. Frontal paralimbic network atrophy in very mild behavioral variant frontotemporal dementia. Arch Neurol: 2008; 65 2 249 255 (Pubitemid 351240789)
21. Ishii K., Sakamoto S., Sasaki M., et al. Cerebral glucose metabolism in patients with frontotemporal dementia. J Nucl Med: 1998; 39 11 1875 1878 (Pubitemid 28518885)
22. Hornberger M., Geng J., Hodges J. R. Convergent grey and white matter evidence of orbitofrontal cortex changes related to disinhibition in behavioural variant frontotemporal dementia. Brain: 2011; 134 Pt 9 2502 2512
23. Rosen H. J., Allison S. C., Schauer G. F., Gorno-Tempini M. L., Weiner M. W., Miller B. L. Neuroanatomical correlates of behavioural disorders in dementia. Brain: 2005; 128 Pt 11 2612 2625 (Pubitemid 41552946)
24. Woolley J. D., Gorno-Tempini M. L., Seeley W. W., et al. Binge eating is associated with right orbitofrontal-insular-striatal atrophy in frontotemporal dementia. Neurology: 2007; 69 14 1424 1433 (Pubitemid 47511464)
25. Whitwell J. L., Sampson E. L., Loy C. T., et al. VBM signatures of abnormal eating behaviours in frontotemporal lobar degeneration. Neuroimage: 2007; 35 1 207 213 (Pubitemid 46240946)
26. Perry D. C., Whitwell J. L., Boeve B. F., et al. Voxel-based morphometry in patients with obsessive-compulsive behaviors in behavioral variant frontotemporal dementia. Eur J Neurol: 2012; 19 6 911 917
27. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry: 1994; 57 4 416 418
28. Neary D., Snowden J. S., Gustafson L., et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology: 1998; 51 6 1546 1554
29. Rascovsky K., Hodges J. R., Kipps C. M., et al. Diagnostic criteria for the behavioral variant of frontotemporal dementia (bvFTD): current limitations and future directions. Alzheimer Dis Assoc Disord: 2007; 21 4 S14 S18 (Pubitemid 350307439)
30. Rascovsky K., Hodges J. R., Knopman D., et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain: 2011; 134 Pt 9 2456 2477
31. Lamarre A. K., Rascovsky K., Bostrom A., et al. Interrater reliability of the new criteria for behavioral variant frontotemporal dementia. Neurology: 2013; 80 21 1973 1977
32. Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr: 1987; 6 3 193 208 (Pubitemid 17140253)
33. Snowden J., Neary D., Mann D. Frontotemporal lobar degeneration: clinical and pathological relationships. Acta Neuropathol: 2007; 114 1 31 38 (Pubitemid 47029057)
34. Urwin H., Josephs K. A., Rohrer J. D., et al. FReJA Consortium. FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration. Acta Neuropathol: 2010; 120 1 33 41
35. Knopman D. S., Mastri A. R., Frey W. H. II, Sung J. H., Rustan T. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology: 1990; 40 2 251 256 (Pubitemid 20099433)
36. Cairns N. J., Bigio E. H., Mackenzie I. R., et al. Consortium for Frontotemporal Lobar Degeneration. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol: 2007; 114 1 5 22 (Pubitemid 47029055)
37. Mackenzie I. R., Neumann M., Baborie A., et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol: 2011; 122 1 111 113
38. Neumann M., Rademakers R., Roeber S., Baker M., Kretzschmar H. A., Mackenzie I. R. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain: 2009; 132 Pt 11 2922 2931
39. Munoz D. G., Neumann M., Kusaka H., et al. FUS pathology in basophilic inclusion body disease. Acta Neuropathol: 2009; 118 5 617 627
40. Neumann M., Roeber S., Kretzschmar H. A., Rademakers R., Baker M., Mackenzie I. R. Abundant FUS-immunoreactive pathology in neuronal intermediate filament inclusion disease. Acta Neuropathol: 2009; 118 5 605 616
41. Goldman J. S., Farmer J. M., Wood E. M., et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology: 2005; 65 11 1817 1819
42. Seelaar H., Kamphorst W., Rosso S. M., et al. Distinct genetic forms of frontotemporal dementia. Neurology: 2008; 71 16 1220 1226
43. Whitwell J. L., Jack C. R. Jr, Boeve B. F., et al. Voxel-based morphometry patterns of atrophy in FTLD with mutations in MAPT or PGRN. Neurology: 2009; 72 9 813 820
44. Le Ber I., Camuzat A., Hannequin D., et al. French research network on FTD/FTD-MND. Phenotype variability in progranulin mutation carriers: a clinical, neuropsychological, imaging and genetic study. Brain: 2008; 131 Pt 3 732 746 (Pubitemid 351294727)
45. Snowden J. S., Rollinson S., Thompson J. C., et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain: 2012; 135 Pt 3 693 708
46. Al-Sarraj S., King A., Troakes C., et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol: 2011; 122 6 691 702
47. Ash P. E., Bieniek K. F., Gendron T. F., et al. Unconventional translation of C9ORF72 GGGGCC expansion generates insoluble polypeptides specific to c9FTD/ALS. Neuron: 2013; 77 4 639 646
48. Gydesen S., Brown J. M., Brun A., et al. Chromosome 3 linked frontotemporal dementia (FTD-3). Neurology: 2002; 59 10 1585 1594 (Pubitemid 35387067)
49. Johnson J. O., Mandrioli J., Benatar M., et al. ITALSGEN Consortium. Exome sequencing reveals VCP mutations as a cause of familial ALS. Neuron: 2010; 68 5 857 864
50. Swartz J. R., Miller B. L., Lesser I. M., Darby A. L. Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors. J Clin Psychiatry: 1997; 58 5 212 216 (Pubitemid 27242008)
51. Ikeda M., Shigenobu K., Fukuhara R., et al. Efficacy of fluvoxamine as a treatment for behavioral symptoms in frontotemporal lobar degeneration patients. Dement Geriatr Cogn Disord: 2004; 17 3 117 121 (Pubitemid 38339734)
52. Moretti R., Torre P., Antonello R. M., Cazzato G., Bava A. Frontotemporal dementia: paroxetine as a possible treatment of behavior symptoms. A randomized, controlled, open 14-month study. Eur Neurol: 2003; 49 1 13 19 (Pubitemid 35477963)
53. Lebert F., Stekke W., Hasenbroekx C., Pasquier F. Frontotemporal dementia: a randomised, controlled trial with trazodone. Dement Geriatr Cogn Disord: 2004; 17 4 355 359 (Pubitemid 38721158)
54. Moretti R., Torre P., Antonello R. M., Cazzato G., Griggio S., Bava A. Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer's disease and other dementias: a 24-month follow-up of 68 patients. Am J Alzheimers Dis Other Demen: 2003; 18 4 205 214 (Pubitemid 37010729)
55. Curtis R. C., Resch D. S. Case of Pick's central lobar atrophy with apparent stabilization of cognitive decline after treatment with risperidone. J Clin Psychopharmacol: 2000; 20 3 384 385 (Pubitemid 30318372)
56. Fellgiebel A., Müller M. J., Hiemke C., Bartenstein P., Schreckenberger M. Clinical improvement in a case of frontotemporal dementia under aripiprazole treatment corresponds to partial recovery of disturbed frontal glucose metabolism. World J Biol Psychiatry: 2007; 8 2 123 126 (Pubitemid 46681093)
57. Mendez M. F., Shapira J. S., McMurtray A., Licht E. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry: 2007; 15 1 84 87 (Pubitemid 46106094)
58. Vercelletto M., Boutoleau-Bretonnière C., Volteau C., et al. French research network on Frontotemporal dementia. Memantine in behavioral variant frontotemporal dementia: negative results. J Alzheimers Dis: 2011; 23 4 749 759
59. Boxer A. L., Knopman D. S., Kaufer D. I., et al. Memantine in patients with frontotemporal lobar degeneration: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol: 2013; 12 2 149 156
60. Merrilees J. A model for management of behavioral symptoms in frontotemporal lobar degeneration. Alzheimer Dis Assoc Disord: 2007; 21 4 S64 S69 (Pubitemid 350307447)